Last reviewed · How we verify
NCT04407845: FABRIC
Atrial Fibrillation in Patients Receiving Ibrutinib
trial in Leukemia, Chronic Lymphatic in 60 participants. Status unknown.
21 May 2022
Quick facts
| Lead sponsor | European Georges Pompidou Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 21 May 2020 |
| Primary completion | 21 May 2022 |
| Estimated completion | 30 November 2022 |
| Sites | 1 location across France |
Conditions studied
- Leukemia, Chronic Lymphatic — all drugs for Leukemia, Chronic Lymphatic →
- Mantle Cell Lymphoma — all drugs for Mantle Cell Lymphoma →
Sponsor
European Georges Pompidou Hospital
Who can join
18 and older, any sex, with Leukemia, Chronic Lymphatic or Mantle Cell Lymphoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Ibrutinib (a tyrosine kinase inhibitor targeting Bruton) is a standard of treatment in haematology. According to retrospective data, atrial fibrillation and systemic hypertension are common ibrutinib-related advserse events. The investigators aim at prospectively establishing the incidence of thesedrug related advsere events through clinical monitoring and attempt at identifying populations at risk.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04407845
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other European Georges Pompidou Hospital trials
Trials by the same sponsor.
- NCT07059715 — Mic Mac: Micro- and Macrocirculatory Assessment During Cardiac Surgery in Patients at Risk of Vasoplegic Syndrome: A Pro · recruiting
- NCT04407858 — Cardiovascular Complications of Carfilzomib · unknown
- NCT07093320 — Saving Limbs After Cancer: Blood Vessel and Soft Tissue Reconstruction Following Sarcoma Surgery in the Legs · completed
- NCT04591509 — Predictability of Echographic Excursion of the Diaphragm for Intubation in COPD- Patients With Acute Respiratory Failure · unknown
- NCT05149261 — Coagulopathy in Acute Aortic Syndrome · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04407845 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by European Georges Pompidou Hospital
- Last refreshed: 9 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04407845.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing